日本NIPRO高钙片(NIPRO)正品的价格
Japan's NIPRO high calcium tablets use calcium aspartate as the core ingredient and are suitable for the calcium supplement needs of people with hypocalcemia, osteoporosis and special physiological stages. This article will provide a detailed analysis of the genuine price, applicable groups and medication precautions to help users choose and use safely and reasonably.
The price of genuine Japanese NIPRO high-calcium tablets (NIPRO)
Japanese NIPRO high-calcium tablets have not been approved for marketing in mainland China, nor have they been included in the medical insurance reimbursement catalog. The specification produced by Nippon New Pharmaceutical Co., Ltd. is 200mg*100 tablets/box, and the international market reference price is about US$20.
Japan’s NIPRO high-calcium tablets have not completed the Chinese drug regulatory approval process. Currently, only the original drugs produced by Japanese original manufacturers are in circulation, and there are no generic drugs yet. Original drugs have significant advantages in ingredient purity, production technology and clinical data support, which is the main reason why their prices are relatively stable.
Consumers should pay attention to checking the manufacturer information, batch number and expiry date on the product packaging when purchasing, and avoid purchasing drugs from informal channels. Choosing a reputable supplier reduces the risk of purchasing counterfeit or expired products.
Special medication groups for Japanese NIPRO high calcium tablets (NIPRO)
People with different physiological states or health conditions need to adjust their medication regimen under the guidance of a doctor. The key points are explained in detail below.
Pregnant and lactating women
Pregnant and lactating women have a significantly increased demand for calcium, and NIPRO high calcium tablets can be used as a supplementary option. However, the total daily intake needs to be strictly controlled to avoid hypercalcemia caused by excessive calcium supplementation. Breastfeeding women need to monitor the calcium content in their milk and adjust the dosage if necessary.
Children and Adolescents
Adolescents during the growth and development period can use this drug under the advice of a doctor, but it is prohibited for infants and newborns under 3 weeks old. Animal experiments show that premature calcium supplementation may affect the development of the hypothalamus, so age restrictions need to be strictly followed.
Elderly patients
Due to reduced calcium metabolism, the elderly need to reduce the dose to 0.6-0.8 grams (3-4 tablets) per day during long-term use, and regularly detect blood calcium and urinary calcium levels to prevent stones or electrolyte disorders.
Patients with renal insufficiency
This drug is contraindicated in patients with severe renal insufficiency. Blocked calcium excretion may lead to elevated blood calcium concentrations and increased cardiovascular risk. Patients with mild or moderate symptoms should use caution and under close monitoring.
Personalized medication plans for special groups can reduce risks, and precautions in daily use cannot be ignored. The following content will analyze the key prevention and control measures.
Precautions for Japanese NIPRO High Calcium Tablets (NIPRO)
Scientific medication can reduce the chance of side effects. The core precautions are listed below.
Avoid drug interactions
Combined use with cardiac glycosides may induce arrhythmia; it must be taken 1-2 hours apart with tetracycline antibiotics or fluoroquinolones to prevent the formation of insoluble complexes that affect absorption. If combined use of vitamin D preparations is required, blood calcium levels should be checked every 3 months.
Correct way to take it
The tablets need to be swallowed whole with warm water. It is forbidden to swallow the PTP aluminum plastic packaging directly. Accidentally swallowing the package may cause esophageal damage. The tablets need to be taken out in advance. It is recommended to take them with meals to reduce gastrointestinal irritation.
When taking it continuously for more than 3 months, blood calcium, urine calcium and renal function tests need to be carried out every six months. If symptoms such as polyuria, thirst, or bone pain occur, you should seek medical attention immediately to check for hypercalcemia.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)